RamuNET-Trial

A multicenter single-arm pilot study of ramucirumab in combination with dacarbazine in patients with progressive well-differentiated metastatic pancreatic neuroendocrine tumors (RamuNet-Trial)

II

interventionell

National

Ramucirumab (Cyramza®); Dacarbazin

Status: In Rekrutierung

Zeitraum

2019

2022

Zentren

8

7

Zentren gesucht

Patienten

45

26

12.04.2022

Klinische Settings

IV

advanced treatment line

palliativ

Beteiligte

AIO-Arbeitsgruppen

Identifier

AIO-NET-0117/ass

AIO-NET-0117/ass

Kontakt

Leitung

Prof. Dr. med. Patrick Michl

Ansprechpartner*in

Prof. Dr. med. Sebastian Krug
E-Mail sebastian.krug@uk-halle.de